retatrutide nejm 2023 obesity trial ly3437943 Early data for demonstrates exceptional weight loss results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading medications currently under Retatrutide (LY3437943) - Phoenix Peptide

[DOI] [PMC free article] [PubMed] [Google Scholar] 173.Nielsen LB, Ploug KB, Swift P, rskov C, Jansen-Olesen I, Chiarelli F, Holst JJ, Hougaard P, Prksen S, Holl R, de Beaufort C, Gammeltoft S, Rorsman P, Mortensen HB, Hansen L

As a starting reference: 10mg in 2mL of bacteriostatic water yields 5mg/mL

Right now I sit at 205 pounds, which puts me 79 pounds lighter than where I started

Clear documentation of medical necessity and patient education about realistic weight loss expectations strengthens prescribing decisions

You accumulate fatigue you cannot recover from, performance spirals, and muscle loss accelerates